ImmunArray, the Richmond, Va. and Rehovot, Israel-based developer of a breakthrough chip-based technology with the capacity to detect the presence of particular auto-antibodies in the blood, has been awarded a $300,000 grant as part of the first phase of the GE NFL Head Health Challenge.
ImmunArray was among 16 grant recipients selected from among more than 400 applicants from leading R&D companies and research universities throughout the country.
Through the grant, ImmunArray researchers will seek to confirm the possible connection between a certain pattern of antibodies associated with acute brain injury and ongoing immunological response to injury. In addition to determining the long-term effects of these acute injury biomarkers, the company’s research also will aid in the development of a simple, convenient, point-of-care blood-based test that can provide diagnostic results quickly and with certainty to those treating athletes or military personnel who have suffered brain injury.
This grant supports the first year of study and can enable a second year of study with the subsequent award of an additional $500,000.